Cellectar Biosciences Inc

NASDAQ:CLRB   3:59:50 PM EDT
0.65
+0.01 (+0.90%)
Earnings Announcements

Cellectar Reports Q3 Loss Per Share of 10 Cents

Published: 11/08/2021 14:06 GMT
Cellectar Biosciences Inc (CLRB) - Cellectar Reports Financial Results for the Third Quarter 2021 and Provides a Corporate Update.
Q3 Loss per Share $0.10.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.10

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.11

More details on our Analysts Page.